In a filing, Veracyte Inc revealed its Chief Executive Officer Stapley Marc unloaded Company’s shares for reported $0.24 million on Dec 13 ’24. In the deal valued at $43.42 per share,5,590 shares were sold. As a result of this transaction, Stapley Marc now holds 307,345 shares worth roughly $12.98 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, MARC STAPLEY bought 5,590 shares, generating $248,196 in total proceeds.
Before that, Febbo Phillip G. sold 3,934 shares. Veracyte Inc shares valued at $173,447 were divested by the Chief Scientific & Med Officer at a price of $44.09 per share. As a result of the transaction, Febbo Phillip G. now holds 82,414 shares, worth roughly $3.48 million.
Goldman downgraded its Veracyte Inc [VCYT] rating to a Neutral from a a Buy in a research note published on December 05, 2024; the price target was decreased to $37 from $38. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid November with a ‘”an Outperform”‘ rating. UBS began covering VCYT with “Buy” recommendation on October 16, 2024. Guggenheim started covering the stock on October 10, 2024. It rated VCYT as “a Buy”.
Price Performance Review of VCYT
On Tuesday, Veracyte Inc [NASDAQ:VCYT] saw its stock fall -2.52% to $42.24. Over the last five days, the stock has lost -1.72%. Veracyte Inc shares have risen nearly 53.54% since the year began. Nevertheless, the stocks have risen 49.95% over the past one year. While a 52-week high of $46.00 was reached on 12/06/24, a 52-week low of $18.61 was recorded on 04/18/24. SMA at 50 days reached $37.89, while 200 days put it at $27.90.
Levels Of Support And Resistance For VCYT Stock
The 24-hour chart illustrates a support level at 41.78, which if violated will result in even more drops to 41.31. On the upside, there is a resistance level at 43.02. A further resistance level may holdings at 43.79. The Relative Strength Index (RSI) on the 14-day chart is 54.91, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 87.14%. Stochastics %K at 39.14% indicates the stock is a holding.
How much short interest is there in Veracyte Inc?
A steep rise in short interest was recorded in Veracyte Inc stocks on 2024-11-29, dropping by -0.14 million shares to a total of 2.97 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-31 was 3.1 million shares. There was a decline of -4.56%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 23, 2024 when Needham resumed its ‘”a Buy”‘ rating for the stock and retained the price target to $33.
